<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(5)</volume><submitter>Kamarajah SK</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Robotic esophagogastric cancer surgery is gaining widespread adoption. This population-based cohort study aimed to compare rates of textbook outcomes (TOs) and survival from robotic minimally invasive techniques for esophagogastric cancer.&lt;h4>Methods&lt;/h4>Data from the United States National Cancer Database (NCDB) (2010-2017) were used to identify patients with non-metastatic esophageal or gastric cancer receiving open surgery (to the esophagus, n = 11,442; stomach, n = 22,183), laparoscopic surgery (to the esophagus [LAMIE], n = 4827; stomach [LAMIG], n = 6359), or robotic surgery (to the esophagus [RAMIE], n = 1657; stomach [RAMIG], n = 1718). The study defined TOs as 15 or more lymph nodes examined, margin-negative resections, hospital stay less than 21 days, no 30-day</pubmed_abstract><journal>Annals of surgical oncology</journal><pagination>2812-2825</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8989809</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes.</pubmed_title><pmcid>PMC8989809</pmcid><pubmed_authors>Phillips AW</pubmed_authors><pubmed_authors>Kamarajah SK</pubmed_authors><pubmed_authors>Ruurda J</pubmed_authors><pubmed_authors>van Hillegersberg R</pubmed_authors><pubmed_authors>Hofstetter WL</pubmed_authors><pubmed_authors>Griffiths EA</pubmed_authors><pubmed_authors>Markar SR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes.</name><description>&lt;h4>Background&lt;/h4>Robotic esophagogastric cancer surgery is gaining widespread adoption. This population-based cohort study aimed to compare rates of textbook outcomes (TOs) and survival from robotic minimally invasive techniques for esophagogastric cancer.&lt;h4>Methods&lt;/h4>Data from the United States National Cancer Database (NCDB) (2010-2017) were used to identify patients with non-metastatic esophageal or gastric cancer receiving open surgery (to the esophagus, n = 11,442; stomach, n = 22,183), laparoscopic surgery (to the esophagus [LAMIE], n = 4827; stomach [LAMIG], n = 6359), or robotic surgery (to the esophagus [RAMIE], n = 1657; stomach [RAMIG], n = 1718). The study defined TOs as 15 or more lymph nodes examined, margin-negative resections, hospital stay less than 21 days, no 30-day</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-05T00:29:02.787Z</modification><creation>2025-04-05T00:29:02.787Z</creation></dates><accession>S-EPMC8989809</accession><cross_references><pubmed>34890023</pubmed><doi>10.1245/s10434-021-11082-y</doi></cross_references></HashMap>